London-based Smith & Nephew announced first quarter revenue at $1.075 billion, down nearly 4 percent from $1.079 billion reported during the same period last year. The company’s operating profit also dipped 4.4 percent from last year, ending the quarter at $241 million.
In its financial report, the orthopedic device manufacturer announced a $300 million share buyback program as part of a new “capital allocation framework.”
More Articles on Devices:
Smith & Nephew to Acquire India-Based Orthopedic Trauma Device Developer
NuVasive Gross Profits Up 4.9% in Q1
Alphatec Spine Gross Profits Increase 2.9% in Q1
In its financial report, the orthopedic device manufacturer announced a $300 million share buyback program as part of a new “capital allocation framework.”
More Articles on Devices:
Smith & Nephew to Acquire India-Based Orthopedic Trauma Device Developer
NuVasive Gross Profits Up 4.9% in Q1
Alphatec Spine Gross Profits Increase 2.9% in Q1